Presentation is loading. Please wait.

Presentation is loading. Please wait.

New Treatment With Human Atrial Natriuretic Peptide for Postoperative Myonephropathic Metabolic Syndrome  Akira Sezai, MD, PhD, Mitsumasa Hata, MD, PhD,

Similar presentations


Presentation on theme: "New Treatment With Human Atrial Natriuretic Peptide for Postoperative Myonephropathic Metabolic Syndrome  Akira Sezai, MD, PhD, Mitsumasa Hata, MD, PhD,"— Presentation transcript:

1 New Treatment With Human Atrial Natriuretic Peptide for Postoperative Myonephropathic Metabolic Syndrome  Akira Sezai, MD, PhD, Mitsumasa Hata, MD, PhD, Tesuya Niino, MD, PhD, Isamu Yoshitake, MD, PhD, Satoshi Unosawa, MD, PhD, Hisaki Umezawa, MD, PhD, Kazutomo Minami, MD, PhD  The Annals of Thoracic Surgery  Volume 88, Issue 4, Pages (October 2009) DOI: /j.athoracsur Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Preoperative computed tomography scan shows acute aortic dissection (arrow, right iliac artery). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Urine volume is shown after the (top panel) AAD repair and (bottom panel) dosage of human atrial natriuretic peptide (hANP). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Changes in concentrations of (top panel) creatine kinase and (bottom panel) creatinine. (ICU = intensive care unit). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "New Treatment With Human Atrial Natriuretic Peptide for Postoperative Myonephropathic Metabolic Syndrome  Akira Sezai, MD, PhD, Mitsumasa Hata, MD, PhD,"

Similar presentations


Ads by Google